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Summary 
Among the general population of Uganda, ex-TB patients are at high risk of chronic cough, phlegm, chest 
pain, haemoptysis and chest x-ray abnormalities. A history of TB was a greater predictor of chronic 
respiratory problems than old age or smoking.  
 
D
ow
nloaded from
 https://academ
ic.oup.com
/cid/advance-article-abstract/doi/10.1093/cid/ciy795/5099459 by London School of H
ygiene & Tropical M
edicine user on 19 Septem
ber 2018
  
ABSTRACT   
Background 
People with pulmonary tuberculosis (TB) are at risk of developing chronic respiratory disorders due to 
residual lung damage. So far, the scope of the problem in high burden TB countries is relatively unknown.  
 
Methods 
Chronic respiratory symptoms (cough and phlegm lasting >2 weeks) and radiological lung abnormalities 
were compared between adults with and without a history of TB among the general population of Uganda. 
Multivariable regression models were used to estimate odds ratios with adjustment for age, gender, 
smoking, education, setting and region. Random effects models accounted for village clustering effect.  
 
Results 
Of 45,293 invited people from 70 villages, 41,154 (90.9%) participated in the survey. 798 had a history of TB 
and among them, 16% had respiratory symptoms and 41% x-ray abnormalities. Adjusted odds ratios 
showed strong evidence for individuals with a history of TB having increased risk of respiratory symptoms 
(OR=4·02, 95%CI: 3·25-4·96) and x-ray abnormalities (OR=17·52, 95%CI: 14·76-20·79); attributing 6% and 
24% of the respective population risks.  
 
Conclusions 
In Uganda, a history of TB was a strong predictor of respiratory symptoms and lung abnormalities, before 
older age and smoking. Eliminating TB disease could reduce the prevalence of chronic respiratory 
symptoms as much as eliminating smoking.  
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BACKGROUND  
 
Tuberculosis (TB) is the biggest cause of death from a single infectious disease resulting in an estimated 
10·4 million new patients and 1·3 million deaths globally in 2016.[1] Uganda has a high burden of TB with an 
estimated incidence of 201 new TB cases and 26 TB-related deaths per 100,000 population per year.[2] Yet, 
TB-associated mortality and morbidity are usually only captured during treatment, while post-treatment 
sequelae are less well documented and recognized. TB disease can lead to chronic lung damage including 
scarring, fibrosis and cavitation, with associated radiological abnormalities.[3, 4] These lung abnormalities are 
the main risk factor for cured TB patients to develop airflow limitations, chronic respiratory symptoms and 
diseases including chronic obstructive pulmonary disease (COPD), bronchiectasis and aspergillosis.[4-8] 
People with post-TB chronic respiratory disorders can be prone to breathlessness, fatigue, physical 
inactivity and psychosocial isolation which have negative consequences for quality of life and earnings.[9, 10]  
 
Simultaneously, chronic respiratory diseases show an increasing global trend with COPD now being the 
third leading cause of death. An estimated 3·2 million people died of COPD in 2015, disproportionately 
affecting people in low- and middle-income countries where diagnosis and treatment are often poor.[11, 12] 
In Uganda, a recent survey in a rural district found a COPD prevalence as high as 16%.[13] Recent 
international surveys have confirmed that TB is an important risk factor of COPD, besides smoking and air 
pollution.[11, 12] A history of TB is estimated to triple the risk of COPD (OR 3·05, 95%CI: 2·42-3·85) and even 
more in countries with a higher TB incidence.[14-17] Despite the emerging evidence on the relationship 
between TB and chronic lung disorders, there is a lack of programmatic recommendations and 
interventions to identify and manage patients beyond their cure of TB.[18, 19] A systematic scoping review 
conducted by the authors found that no international TB guidelines addressed the issue.[20] There is a 
limited number of studies on the prevalence of post-TB lung disorders, especially from Sub-Saharan 
Africa.[16, 17, 21] One study from South Africa assessed post-TB chronic bronchitis (cough and phlegm ≥ 3 
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months) through a national survey in 2004, but did not include other respiratory symtopms or chest x-ray 
abnormalities.[22] Few studies in general have related structural lung damage to respiratory symptoms.[4] To 
contribute to the evidence on post-TB lung disorders, this study assessed a range of chronic respiratory 
symptoms and radiological abnormalities among the general population of Uganda using data from the 
most recent national TB prevalence survey.  
 
METHODS  
 
Study design and population 
This study used data from the national TB prevalence survey of Uganda conducted in 2014-2015 by the 
Ministry of Health together with Makerere University, WHO and Centers for Disease Control and 
Prevention.[23] In the original survey, a national representative sample was obtained using the entire 
country as the sampling frame and villages as the sampling units. Villages were stratified by rural and urban 
settings and a total of 70 villages with between 550 and 680 eligible respondents were selected with 
probability proportionate to population size. All households in a selected village were included. All 
consenting permanent residents and those visiting the residence since more than two weeks aged 15 years 
and above were eligible.  
 
Ethical approval of the original survey was granted by the Institutional Review Boards of the Higher Degree 
Research and Ethics Committee (HDREC) at the Makerere University School of Public Health and the 
Uganda National Council of Science and Technology (UNCST), under reference number IRB00011353.  
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Data collection 
Data for the original household survey was collected from October 2014 to July 2015. Participants were 
interviewed with a questionnaire on demographics, clinical symptoms, smoking behaviour, and current and 
past TB treatment (see Box 1). Subsequently, all people received a chest x-ray to assess lung abnormalities 
as per WHO guidelines. The films were read by radiology consultants from the national lung hospital. 
Participants with cough for two weeks or more and/or an abnormal chest x-ray were asked to provide two 
sputum samples for bacteriological tests for active TB disease (smear microscopy, GeneXpert, culture). 
Participant data from questionnaires, chest x-rays and laboratory tests were entered, cleaned, verified and 
anonymised in an electronic database using EpiInfo version 3.51.  
 
For the present study, people with current TB were excluded, i.e. those who reported to be taking anti-TB 
drugs or who were diagnosed with active TB disease during the survey. People with a history of TB were 
those who self-reported to ever have been treated for TB in their lifetime but did not have current TB 
disease. Regions represented statistical groupings of districts without administrative or political status as 
used in the 2002 Uganda Census.[24] 
 
Outcomes 
Respiratory symptoms 
Respiratory symptoms were recorded as self-reported presence or absence and duration in days of: cough; 
phlegm; haemoptysis; and chest pain. A composite binary outcome for chronic respiratory symptoms 
(presence or absence) was constructed based on cough and phlegm: people who reported both cough and 
phlegm of two weeks or more were classified as having chronic respiratory symptoms. Haemoptysis was 
not included in the composite outcome because this is a rare symptom of severe chronic respiratory 
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disease. Chest pain, although potentially linked to respiratory problems, is not a distinguishing symptom of 
chronic lung disease.[9]  
 
Lung abnormalities 
Radiological lung abnormalities were based on chest x-ray reports, which for this analysis were converted 
from a categorical to a binary variable, i.e.: reports of inactive/healed TB, suggestive active TB disease and 
other lung abnormalities, whether or not they were thought to be consistent with TB, were regrouped as 
presence of lung abnormalities; normal readings and extra-pulmonary abnormalities were regrouped as 
absence of lung abnormalities; poor x-ray/not read and missing readings were recoded as missing.  
 
Statistical analysis 
The proportion of chronic respiratory symptoms and radiological lung abnormalities was presented for the 
overall study population and for people with and without a history of TB. This study had 90% power at a 
two-sided 5% significance level to detect a proportional difference of 2.5% for the main outcomes between 
people with and without a history of TB. Crude odds ratios of the association between past TB and both 
outcomes were calculated with 95% confidence intervals and Chi-square tests. Multivariable logistic 
regression models were used to adjust for age, gender, smoking, education, region and setting. Multi-
collinearity between these variables was assessed using variance inflation factors (VIF) and variables were 
dropped from the model if VIF>10. Adjustment for village clustering was done using a random effects 
model. Effect modifiers were included in the final model if the effect on outcomes varied dramatically (i.e. 
reverse direction) across variable subgroups. Finally, population attributable risk fractions were calculated 
for the two main outcomes using standard formulas. Statistical analyses were performed using STATA 
version SE14. 
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Sensitivity analyses were performed to explore the impact of different outcome definitions. First, we 
estimated the odds ratios for chronic respiratory symptoms using a three-month cut-off point rather than 
two weeks, as GOLD guidelines do not specify the minimum duration of respiratory symptoms for 
classification of e.g. COPD.[9]  Secondly, we estimated the odds ratio of radiological lung abnormalities 
reclassifying people with ‘inactive/healed TB’ as having no lung abnormalities, since some ex-TB patients 
could have for example calcified lymph nodes without ever developing respiratory disorders.  
 
RESULTS  
 
Of 45,293 eligible individuals, 41,154 (90.9%) received symptoms screening and/or chest x-ray scans. After 
excluding 205 people with current TB, 40,949 people remained of whom 204 (<1%) had missing chest x-ray 
data (respiratory symptom data was complete). Table 1 shows the characteristics of the study population. A 
total of 798 out of 40,949 people (1·9%) reported a history of TB and 40,151 (98·1%) reported no history of 
TB. People with a history of TB were more often male (52·9%), living in the north (31·3%) or central region 
(35·3%), living in urban settings (47·1%), past (20·9%) or current smokers (10·0%), and older than people 
without a history of TB.  
 
Table 2 shows the proportion of people with chronic respiratory symptoms (individual and composite) and 
radiological lung abnormalities. As many as 21% of the general population reported chest pain. Among 
people with a history of TB, 16% reported cough and phlegm, 41% had lung abnormalities and 9% had both. 
A history of TB was crudely associated with cough and phlegm (OR 4·95, 95%CI: 4·06-6·05), as well as lung 
abnormalities (OR 21·79, 95%CI: 18·60-25·53). Although symptoms and lung damage were highly correlated 
(p<0.0001), the majority of people with lung abnormalities did not report cough and phlegm (78%; 
253/326), and some with symptoms had no lung abnormalities (41%; 50/123). Still, people with past TB and 
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lung abnormalities had 2.41 (95%CI: 1.62-3.58) times the odds of respiratory symptoms than those with no 
x-ray abnormalities.  
 
Age, smoking, gender, region, setting and education were included as potential confounders in a 
multivariable logistic regression model. None of the variables showed multi-collinearity (all VIF<1·2). Table 
3 shows that after adjusting for these factors, as well as for village clustering effect, there was still a 
significant association between a history of TB and respiratory symptoms. People with a history of TB had 
4·02 (95%CI: 3·25-4·96; p<0·001) times the odds of chronic cough and phlegm than people without a 
history of TB. The odds of having respiratory symptoms also increased with older age and smoking, while 
living in the western region of the country and having a higher education decreased the odds. The within-
village correlation coefficient (rho=0.041, 95%CI: 0.026-0.064, p<0·001) indicated that people living within 
the same village were indeed more similar than people living in different villages. 
 
Table 4 shows that after adjusting for all variables and village clustering effect, people with a history of TB 
had 17·52 (95%CI:14·76-20·79) times the odds of lung abnormalities than people without a history of TB. 
The village clustering effect was again significant (rho=0·020, 95%CI: 0·011-0·036, p<0·001). While the odd 
ratio of lung abnormalities varied widely across age groups (LRT p=0.0001), from 27·34 (95%CI: 16·49-
45·34) among 15-24 year olds to 8·18 (95%CI: 5·11-13·11) among 65+ year olds, age did not actually reverse 
the effect of TB history on lung abnormalities and was therefore not included as effect modifier in the final 
model. Besides a history of TB, the odds of having lung abnormalities increased with older age and past or 
current smoking, while living in the western region of the country and higher education decreased the 
odds. Women had only half the odds of having lung abnormalities than men.  
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A history of TB attributed an estimated 6% of the population’s risk of chronic respiratory symptoms and 
24% of the risk of radiological lung abnormalities. In comparison, older age (65+ years) imposed the largest 
population risk on both outcomes (14% and 42%, respectively), while current smoking had a similar impact 
on respiratory symptoms (7%) and a much smaller impact on lung abnormalities (5%) than a history of TB.   
 
A sensitivity analysis around chronic respiratory symptoms showed that using a cut-off point of three 
months rather than two weeks actually increased the crude odds ratio from 4·95 to 7·54 (95%CI: 5·14-
11·07) and the fully-adjusted odds ratio from 4·02 to 5·19 (95%CI: 3·43-7·84), which suggested a stronger 
impact of a history of TB on long-term rather than short-term respiratory symptoms.  A sensitivity analysis 
around radiological lung abnormalities showed that excluding people with ‘inactive/healed TB’ on chest x-
ray would reduce the crude odds ratio from 21·79 to 8·67 (95%CI: 7·21-10·43) and the fully-adjusted odds 
ratio from 17·52 to 5·87 (95%CI: 4·81-7·15). This was driven by the association between a history of TB and 
radiological signs of previous TB disease. Further inspection revealed that 74% of people with 
‘inactive/healed TB’ had atelectasis (lung collapse) and 42% had fibrosis, both commonly associated with 
respiratory disorders, thus excluding them would underestimate the effect of a history of TB on lung 
abnormalities.  
 
DISCUSSION  
 
This study assessed the scope of post-TB chronic respiratory symptoms and lung abnormalities among the 
general population of Uganda and found that people with a history of TB had four times the odds of having 
chronic respiratory symptoms and 18 times the odds of radiological lung abnormalities compared to people 
without a history of TB. Chronic cough, phlegm, chest pain and haemoptysis were all significantly more 
prevalent among people with than without a history of TB. At individual level, a history of TB was a very 
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strong predictor of respiratory problems even before older age and smoking. At population level, a history 
of TB was at par with smoking and only surpassed by old age in terms of attributable risk. Our sensitivity 
analyses showed that even when chronic symptoms and lung abnormalities were defined more 
conservatively, strong evidence for an impact of past TB as a risk factor remained. These findings are 
consistent with a previous study from South Africa, which found odds ratios for chronic bronchitis of 4·9 
(95%CI:2·6-9·1) for men and 6·6 (95%CI:3·7-11·7) for women with past TB.[22] Those findings may have been 
slightly overestimated as the study did not exclude people with active TB disease. Most other studies on 
respiratory symptoms or lung abnormalities have been conducted in occupational or clinical settings and 
were less comparable. This is the first study to report on the national proportion of post-TB lung 
abnormalities and compare it with respiratory symptoms. The fact that the majority of people with lung 
abnormalities did not report respiratory symptoms indicates that lung damage, although doubling the risk, 
does not always lead to respiratory disease.  
 
Men had almost twice the odds of lung abnormalities than women after controlling for other factors 
including TB history and smoking. This warrants further exploration as we are not aware of any studies 
reporting a similar finding. Occupational exposure could be higher in men, but would likely be outweighed 
by women being more exposed to household air pollution. Delays to diagnosis of TB, potentially leading to 
increased lung damage, also tend to be higher among women.[25] People with higher levels of education 
were less prone to post-TB problems possibly because they were on average wealthier, had better access 
to health services, and less often used biomass fuel for cooking. People living in the western region of 
Uganda had reduced risks, which might be due to environmental, cultural or genetic variations that can be 
explored in further studies. Older age increases the risk of respiratory disorders because of deterioration of 
the lungs over a lifetime and cumulative lung damage resulting from environmental exposures and other 
lung insults. Smoking is known to be the most common cause of chronic airflow obstruction in high income 
countries.[26] Interestingly, this study has brought to light that eliminating TB disease in the population of 
Uganda could result in at least as large a reduction of chronic respiratory symptoms as eliminating smoking. 
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The strength of this study was the large, nationally representative sample of over 40,000 people. The study 
population was similar to the general population of Uganda as measured by the 2014 Census in terms of 
gender (51% females), age (5% 65+ years) and education (19% without formal education).[27] The findings 
are therefore likely to be generalizable to the whole country and to other countries with similar TB 
epidemiology and demographics. This study also had some limitations. First, this study was not able to 
control for potential confounding by household smoke exposure, outside air pollution, occupational 
exposure to e.g. dust or silica, diabetes and HIV status. Although rural/urban setting could partly serve as 
proxy for inside/outside air pollution and occupational expsoure, positive confounding by these factors 
cannot be excluded. Secondly, there was a risk of recall bias due to the fact that TB history and respiratory 
symptoms were self-reported and not verified by clinical assessments or historical records. People with 
either of these may remember and report the presence of the other more actively, which could potentially 
have slightly overestimated our associations. Thirdly, there may have been a small risk of selection bias as 
9% of the study population was excluded due to missing data. However, since the excluded group was on 
average younger, including them would likely have increased the association between a history of TB and 
lung abnormalities. Lastly, there was a risk of survival bias as only those people who survived longer post-
TB will have been included in the survey and those might be the ones with milder respiratory problems. If 
this study missed some people with severe chronic lung disorders due to premature mortality, then our 
already strong associations would have been underestimated.  
Future cohort studies should evaluate the potential effect of time since last TB treatment and potential 
confounders such as indoor and outdoor air pollution and co-morbidities. Future population based studies 
that enquire about chronic respiratory symptoms should also include measures of lung function 
(spirometry), dyspnoea and wheeze in order to diagnose disorders like COPD and bronchiectasis. 
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While post-TB chronic lung disorders can primarily be reduced by adequate and timely treatment and 
prevention of active TB disease, it is equally imperative to monitor and manage respiratory problems after 
cure of TB. People at risk of chronic respiratory problems should be identified as early as possible in order 
to optimize prognosis and treatment outcomes, for example by offering clinical symptom assessment, chest 
x-ray scans and lung function tests immediately or a few months after being cured of TB. They are likely to 
benefit most from interventions including smoking cessation, patient education for self-management, 
pulmonary rehabilitation and bronchodilator therapy.[9, 28] The tremendous expense and disability 
associated with chronic lung diseases in North America and Europe has important implications for the 
future of low resource countries like Uganda.[29] Even though international guidance is lacking, Uganda has 
very recently included the issue of post-TB lung disorders into its national TB programme guidelines. Also, a 
preliminary study of pulmonary rehabilitation showed major improvements in dyspnoea, exercise capacity 
and chest pains among ex-TB patients.[30] It is important for more high burden TB countries and 
international policy makers and researchers to consider and address the issue of post-TB lung disorders if 
we are to reduce overall TB-related morbidity and mortality.  
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Table 1. Characteristics of the study population and among people with and without a history of TB 
among the general population of Uganda in 2014-2015 
Demographics Categories Total  
(n=40,949) 
History of TB 
(n=798)  
No history of 
TB (n=40,151)  
Crude association Chi-
square 
test  
n (%) n (%) n (%) Odds ratio    (95% 
CI) 
 p-value 
Age 15-24 years 14738 (35·99) 109 (13·66) 14629 (36·43) 1.00 - 
25-34 years 10494 (25·63) 170 (21·30) 10324 (25·71) 2.21 (1.73, 2.82) <0·0001 
35-44 years 6785 (16·57) 175 (21·93) 6610 (16·46) 3.55 (2.79, 4.52) <0·0001 
45-54 years 4246 (10·37) 179 (22·43) 4067 (10·13) 5.91 (4.64, 7.53) <0·0001 
55-64 years 2203 (5·38) 79 (9·90) 2124 (5·29) 4.99 (3.72, 6.70) <0·0001 
65+ years 2483 (6·06) 86 (10·78) 2397 (5·97) 4.82 (3.61, 6.42) <0·0001 
Gender Male 17340 (42·35) 422 (52·88) 16918 (42·14) 1·54 (1·34, 1·77) <0·0001 
Female 23609 (57·65) 376 (47·12) 23233 (57·86) 1·00 - 
Education 
a
 None 6959 (16·99) 177 (22·18) 6782 (16·89) 1·13 (0·84, 1·52) 0·423 
Primary 19780 (48·30) 353 (44·24) 19427 (48·38) 0·79 (0·60, 1·04) 0·087 
Senior 1-4 9897 (24·17) 173 (21·68) 9724 (24·22) 0·77 (0·57, 1·04) 0·083 
Senior 5-6 1655 (4·04) 35 (4·39) 1620 (4·03) 0·93 (0·61, 1·42) 0·752 
Tertiary 2655 (6·48) 60 (7·52) 2595 (6·46) 1·00 - 
Region 
b
 Central 13876 (33·89) 282 (35·34) 13594 (33·86) 1·47 (1·19, 1·82) 0·0003 
East 8960 (21·88) 136 (17·04) 8824 (21·98) 1·09 (0·86, 1·39) 0·466 
North 8752 (21·37) 250 (31·33) 8502 (21·18) 2·09 (1·69, 2·59) <0·0001 
West 9360 (22·86) 130 (16·29) 9230 (22·99) 1·00 - 
Setting Rural 23705 (57·89) 422 (52·88) 23283 (57·99) 1·00 - 
Urban 17244 (42·11) 376 (47·12) 16868 (42·01) 1·23 (1·07, 1·42) 0·004 
Smoking 
c
 Never smoked 35290 (86·19) 551 (69·05) 34739 (86·53) 1·00 - 
Past smoker 2674 (6·53) 167 (20·93) 2507 (6·24) 4·20 (3·51, 5·02) <0·0001 
Current smoker 2979 (7·28) 80 (10·03) 2899 (7·22) 1·74 (1·37, 2·21) <0·0001 
a 
Education level: missing for 3 out of 40,949 participants (0·007%)
 
b 
Region as per 2002 Uganda population and housing census 
[24]
: missing for 1 out of 40,949 participants (0·002%)
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c 
Smoking: missing for 6 out of 40,949 participants (0·01%) 
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Table 2. Proportion and unadjusted crude associations between having a history of TB and chronic 
respiratory proportion among the general population of Uganda in 2014-2015 
Outcomes Categories Total  
(n=40949) 
History of TB 
(n=798) 
No history of TB 
(n=40151)  
Crude 
association 
Chi-square test  
n (%) n (%) n (%) Odds ratio (95% 
CI) 
 p-value 
Cough  
>2 weeks 
Yes 2610 (6·37) 155 (19·42) 2455 (6·11) 3·70 (3·09, 4·43) <0·0001 
No 38339 (93·63) 643 (80·58) 37696 (93·89) 1·00 -- 
Phlegm  
>2 weeks 
Yes 1692 (4·13)  129 (16·17)  1563 (3·89) 4·76 (3·91, 5·79)  <0·0001 
No 39257 (95·87)  669 (83·83)  38588 (96·11) 1·00 -- 
Haemoptys
is  
>2 weeks 
Yes 112 (0·27)  17 (2·13)  95 (0·24) 9·18 (5·45, 15·46)  <0·0001 
No 40837 (99·73)  781 (97·87)  40056 (99·76) 1·00 -- 
Chest pain  
>2 weeks 
Yes 8578 (20·95)  257 (32·21)  8321 (20·72) 1·82 (1·56, 2·11)  <0·0001 
No 32371 (79·05)  541 (67·79)  31830 (79·28) 1·00 -- 
Chest x-ray 
results 
Normal 38,421 (93·8) 450 (56·39) 37971 (94·57) N/A N/A 
 Inactive/healed 
TB 
265 (0·7) 165 (20·68) 100 (0·25)   
Extra-pulmonary 
abnormalities 
758 (1·9) 17 (2·13) 741 (1·85)   
Active TB 
diseases 
suggestive 
146 (0·4) 56 (7·02) 90 (0·22)   
Other findings 
consistent with 
TB 
294 (0·7) 44 (5·51) 250 (0·62)   
Other findings 
not consistent 
with TB 
861 (2·1) 61 (7·64) 800 (1·99)   
Poor x-ray/not 
read 
56 (0·1) 1 (0·13) 55 (0·14   
Missing 148 (0·4) 4 (0·50) 144 (0·36)   
Main 
outcomes 
 
Cough and Yes 1562 (3·81) 124 (15·54) 1438 (3·58) 4·95 (4·06, 6·05) <0·0001 
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phlegm >2 
weeks 
a
 
No 39387 (96·19) 674 (84·46) 38713 (96·42) 1·00 -- 
Radiologica
l lung 
abnormaliti
es 
b
 
Yes 1566 (3·84) 326 (41·11) 1240 (3·10) 21·79 (18·60, 
25·53)  
<0·0001 
No 39179 (96·16) 467 (58·89) 38712 (96·90) 1·00 -- 
a
 Composite outcome for respiratory symptoms, combining people with cough and phlegm lasting 14 days or more 
 
b
 Combining people with inactive/healed TB, active TB diseases, or other lung conditions whether consistent or not 
consistent with TB; missing for 204 participants (<1%) 
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Table 3. Multivariable logistic regression model for the association between a history of TB and 
respiratory symptoms adjusted for confounding and clustering 
Variables included in the final model for 
COUGH AND PHLEGM > 2 WEEKS 
Fully-adjusted 
association  
Wald test 
 
Odds ratio (95% CI) p-value 
History of TB  4·02 (3·25, 4·96) <0·001 
Age group (15-24 years) -- -- 
       25-34 years 1·29 (1·10, 1·52) 0·002 
       35-44 years 1·48 (1·24, 1·75) <0·001 
       45-54 years 1·75 (1·46, 2·11) <0·001 
       55-64 years 1·93 (1·55, 2·41) <0·001 
       65+ years 3·75 (3·10, 4·53) <0·001 
Smoking (never smoked) -- -- 
       Past smoker 1·48 (1·24, 1·77) <0·001 
       Current smoker 2·00 (1·70, 2·36) <0·001 
Region 
a
 (central) -- -- 
       East 0·99 (0·74, 1·32) 0·943 
      North 1·11 (0·83, 1·47) 0·482 
      West 0·56 (0·42, 0·75) <0·001 
Setting (rural) -- -- 
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      Urban 0·86 (0·69, 1·07) 0·172 
Education (no education) -- -- 
     Primary 0·74 (0·65, 0·85) <0·001 
     Senior 1-4 0·53 (0·45, 0·64) <0·001 
     Senior 5-6 0·35 (0·23, 0·54) <0·001 
     Tertiary 0·35 (0·26, 0·49) <0·001 
Gender (male) -- -- 
     Female 0·90 (0·80, 1·01) 0·087 
Village clustering effect Rho (95% CI) LRT 
b
 p-value 
     Correlation coefficient  0.041 (0.026, 0.064) <0.001 
a 
Region as per 2002 Uganda population and housing survey 
[24] 
b
 LRT; likelihood ratio test 
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Table 4. Multivariable logistic regression model for the association between a history of TB and 
radiological lung abnormalities adjusted for confounding and clustering 
Variables included in the final model for 
RADIOLOGICAL LUNG ABNORMALITIES 
Fully-adjusted 
association  
Wald test 
 
Odds ratio (95% CI) p-value 
History of TB  17·52 (14·76, 20·79) <0·001 
Age group (15-24 years) -- -- 
       25-34 years 1·90 (1·54, 2·34) <0·001 
       35-44 years 3·20 (2·60, 3·94) <0·001 
       45-54 years 4·85 (3·92, 5·99) <0·001 
       55-64 years 6·74 (5·34, 8·52) <0·001 
       65+ years 13·16 (10·61, 16·32) <0·001 
Smoking (never smoked) -- -- 
       Past smoker 1·43 (1·22, 1·68) <0·001 
       Current smoker 1·66 (1·41, 1·95) <0·001 
Region 
a
 (central) -- -- 
       East 0·93 (0·76, 1·13) 0·474 
      North 0·94 (0·77, 1·13) 0·498 
      West 0·73 (0·60, 0·88) 0·001 
Setting (rural) -- -- 
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      Urban 1·09 (0·94, 1·26) 0·263 
Education (no education) -- -- 
     Primary 0·87 (0·75, 1·00) 0·048 
     Senior 1-4 0·70 (0·58, 0·85) <0·001 
     Senior 5-6 0·48 (0·31, 0·73) 0·001 
     Tertiary 0·72 (0·55, 0·94) 0·018 
Gender (male) -- -- 
     Female 0·47 (0·42, 0·54) <0·001 
Village clustering effect Rho (95% CI) LRT 
b
 p-value 
     Correlation coefficient  0.011 (0.0045, 0.025) 0.001 
a 
Region as per 2002 Uganda population and housing survey 
[24]
 
 
b
 LRT; likelihood ratio test 
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